References
-
1
Czeizel A E, Intödy Z S, Modell B.
What proportion of congenital abnormalities can be prevented?.
BMJ.
1993;
306
499-503.
-
2
Smithells R W, Sheppard S, Wild J, Schorah C J.
Prevention of neural tube defect recurrences in Yorkshire: final report.
Lancet.
1989;
ii (8661)
498-499.
-
3
Nevin N C, Seller M J.
Prevention of neural-tube-defect recurrences.
Lancet.
1990;
335
178-179.
-
4 MCR Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991 338: 131-137.
-
5
Czeizel A E.
Ten years of experience in periconceptional care.
Eur J Obstet Gynecol Reprod Biol.
1999;
84
43-49.
-
6
Czeizel A E, Dudás I.
Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.
N Engl J Med.
1992;
327
1832-1835.
-
7
Czeizel A E.
Prevention of congenital abnormalities by periconceptional multivitamin supplementation.
BMJ.
1993;
306
1645-1648.
-
8
Czeizel A E.
Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation.
Am J Med Genet.
1996;
62
179-183.
-
9
Czeizel A E, Dobo M, Vargha P.
Hungarian cohort controlled trial of periconceptional multivitamin supplementation shows reduction in certain congenital abnormalities.
Birth Defects Res A Clin Mol Teratol.
2004;
70
853-861.
-
10
Botto L D, Olney R S, Erickson J D.
Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
Am J Med Genet C Semin Med Genet.
2004;
125
12-21.
-
11
Czeizel A E, Timár I, Sárközi A.
Dose-dependent effect of folic acid on the prevention of orofacial clefts.
Pediatrics.
1999;
104
e66.
-
12 Taruscio D. (Ed.) .Folic Acid: from Research to Public Health Practice. Rapporti ISTISAN Roma; 2004: 26.
1 Summary of a lecture held at the 9th symposium of Gesellschaft für angewandte Vitaminforschung e.V. - GVF. Bonn, 28.06.2006.
Prof. Andrew E. Czeizel
Scientific Director of the Foundation for the Community Control of Hereditary Diseases
Budapest, Hungary
